Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07279506Not ApplicableNot Yet Recruiting

Clinical Investigation of IXIUM TWIN Viscoelastic Ophthalmic Device For Cataract Surgery

Role: lead

NCT06228274Completed

Assessment of Safety and Efficacy of ARTHRUM 2.5% for Treatment of Painful Osteoarthritis of the Knee

Role: lead

NCT02840422Completed

Assessment of Patients Quality of Life Treated With Three ARTHRUM H 2% Joint Injections

Role: lead

NCT06087705Unknown

Real-life Assessment of the Safety and Performance of the SYNOVIUM HCS Device

Role: lead

All 4 trials loaded